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Abstract
Despite the regular treatment with inhaled corticosteroids (ICS) or ICS plus long-acting beta2-agonists, permits to
control de majority of asthmatics, a significant proportion of patients does not respond to this treatment.
This review was aimed to explore the role of psychological factors associated to the unsuccessful fulfilment of
optimal levels of asthma control, especially in patients suffering from severe asthma. The results of a Medline search
were 5510 articles addressed to different psychological key concepts, constructs and variables. This review will
highlight how some selected psychological factors may have a burden on asthma management. Evidences are
now available about the link between asthma (in terms of severity and control), some psychological aspects
(subjective perception, alexithymia, coping style) and mental health (anxiety, depression). Taking into account this
most probably bidirectional influence, a screening of mental symptoms and psychological aspects related to
asthma, could lead to plan appropriate interventions to better control asthma and to improve the patient’s well-
being.
Introduction
It is now well recognized that the regular treatment with
inhaled corticosteroids (ICS) or ICS plus long-acting
beta2-agonists (LABA), permits to control the majority
of asthmatics. However, a significant proportion of pa-
tients does not respond to this treatment [1, 2]. It has
been estimated that severe asthma accounts for approxi-
mately 5–10 % of the total asthmatic population [3, 4]:
this range most likely depends on changing definitions
and criteria adopted in the past decades. Recently, a Task
Force, supported by the European Respiratory Society
(ERS) and American Thoracic Society (ATS) [5], proposed
a revised definition of severe asthma in children ≥6 years
and adults.
Severe asthma has been defined (5) as asthma which re-
quires treatment with guidelines suggested medications
for GINA steps 4–5 asthma (high dose ICS and LABA or
leukotriene modifier/theophylline) for the previous year or
systemic CS for ≥50 % of the previous year to prevent it
from becoming “uncontrolled” or which remains “uncon-
trolled” despite this therapy (as described in Table 1). The
definition of high dose inhaled corticosteroids (ICS) is
age-specific.
The aim of asthma therapy is to reach and maintain the
disease control, minimizing symptoms, daily activity limi-
tation, and the risks for life-threatening exacerbations and
long-term morbidity [6]. As available population-based
studies clearly illustrate, in a large portion of asthma pa-
tients a satisfactory level of disease control is not achieved.
In the Asthma Insights and Reality in Europe (AIRE)
study, involving more than 2,800 subjects living in differ-
ent European countries, more than 50 % of the inter-
viewees exhibited daytime symptoms and one out of three
respondents experienced asthma-related sleep problems
[7]. In the International Asthma Patient Insight Research
(INSPIRE) study 3,415 treated asthma adults were inter-
viewed by telephone [8], nearly 74 % used a short-acting
bronchodilator every day, and 51 % had at least one ex-
acerbation that required medical treatment in the past
year.
An incomplete success of asthma treatment may depend
on the presence and interaction of different causes related
to the disease itself (i.e. triggers, comorbidities, asthma
phenotype), the treatment (i.e. inadequate treatment, inad-
equate inhaler device), the patient (i.e. socio-demographic
factors, adherence, knowledge), the physician (i.e. lack of
consciousness and familiarity about guidelines) [9].
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Nevertheless, different psychological factors play a pri-
mary role in daily asthma management. The ideas that the
patient has regarding asthma, the impact of the disease on
daily life, the subjective interpretation of symptoms, and
therapeutic adherence can be significantly influenced by
psychological aspects. Moreover, the presence of the dis-
ease itself may have an impact on patients’ affective
sphere, representing an obstacle to an optimal disease
management. It is now recognized that asthma can influ-
ence mental health and vice versa [10, 11], and that a link
exist between psychological functioning and level of
asthma control [12].
The purpose of this review is to explore how different
psychological aspects may be associated to the unsuc-
cessful fulfilment of optimal levels of asthma control, es-
pecially in patients suffering from severe asthma.
To address this issue, Medline searches were per-
formed by pairing the word ‘asthma’ with the following
keywords: psychological factors, psychological disorders,
and psychological characteristics. The results of our search
were 5510 articles addressed to different psychological key
concepts, constructs and variables. This review will high-
light how some selected psychological factors may have a
burden on asthma management.
Review
Specific psychological factors that likely affect asthma
experience and management
Symptoms’ subjective perception, alexithymia, coping
strategies, depression and anxiety are the psychological
factors that, in cognitive or in emotional dimensions, are
most involved in Asthma experience and management.
The personal report of disease, the difficulty in recog-
nizing feelings and sensations, the ability to solve prob-
lems and tolerate stress, the presence of emotional and
mental health disorders, can influence the success of the
treatment and the prognosis of the disease.
The relationship between each dimension and the ex-
perience of Asthma will be analyzed in detail.
Symptoms’ subjective perception
Patients’ report of symptoms constitutes an important
factor in determining the diagnosis of asthma and in in-
fluencing the treatment plan. However, self-reported
symptoms poorly correlate with pulmonary function
measures and the perception is not necessarily linearly
related to the sensory input: patients may exhibit limited
disease severity, but describe high levels of dyspnea, or
vice versa. From 15 to 60 % of patients [13], depending
on the measurements used, report difficulty in recogniz-
ing their own degree of airway obstruction. Poor symp-
tom perception may result in a significant overuse of
reliever medication, irrespective of lung function,
whereas under-perception presents the potential risk of
delayed treatment. In a 2-year follow-up, patients with
both increased and decreased symptom perception ex-
hibited a four-fold increased rate of visits to the emer-
gency department, a five-fold increased hospitalization
rate, and a six-fold increased rate of nearly fatal or fatal
asthma attacks [14]. As these findings show, perception
represents a relevant key factor in the management of
this chronic condition.
A study of Lurie [15] shows that the variables actually
used by patients to determine the severity of their asthma,
are very different from those that doctors employ to assess
and monitor asthma severity and, in general, patients have
the tendency to underestimate the level of disease severity.
The accuracy of symptom perception depends on a wide
variety of cognitive and affective variables, such as emo-
tional state, previous life experiences, attributions, con-
textual information, attentional and learning processes,
expectation and prior asthma experiences, personality
traits, and psychopathologic disturbances. All these factors
can profoundly affect the perception of dyspnea and asth-
matic symptoms, often independent of airflow obstruc-
tion. Many subjects with asthma learn to associate
negative situations and emotional distress with difficult
breathing and are thus likely to over-perceive dyspnea.
Studies in healthy volunteers and asthma patients dem-
onstrate that subjects with high negative emotionality,
tend to report more dyspnea than those with low negative
emotionality. Similarly, the experimental induction of
negative affective states in healthy individuals and patients
in able to increase reports of respiratory sensations such
as dyspnea. The feeling of unpleasantness related to dys-
pnea, rather than its sensory intensity, appears to be re-
lated to affective influences [16]. Individuals with asthma
may under-perceive dyspnea when experiencing a positive
Table 1 The definition of uncontrolled asthma [5]
Uncontrolled asthma defined as at least one of the following:
1) Poor symptom control: ACQ consistently >1.5, ACT <20
(or “not well controlled” according NAEPP/GINA guidelines);
2) Frequent severe exacerbations: two or more bursts of systemic CS
(>3 days each) in the previous year;
3) Serious exacerbations: at least one hospitalisation, ICU stay or
mechanical ventilation in the previous year;
4) Airflow limitation: after appropriate bronchodilator withhold FEV1 <
80 % predicted (in the face of reduced FEV1/FVC defined as less than
the lower limit of normal);
Controlled asthma that worsens on tapering of these high doses of ICS
or systemic CS (or additional biologics)
*
GINA Global initiative for asthma, ICS Inhaled corticosteroids, LABA, Long-acting
beta2-agonists, CS Corticosteroids, ACQ Asthma control questionnaire, ACT
Asthma control test, NAEPP National asthma education and prevention
program, ICU Intensive care unit, FEV1 Forced expiratory volume in the first
second, FVC Forced vital capacity
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emotional state, potentially reducing the use of prescribed
medications [17].
Alexithymia
Alexithymia, a term derived from the Greek words alexis
(“no words”) and thymos (“emotion”), is a personality
trait characterized. As presently defined, the alexithymia
construct is composed of the following factors: (i) diffi-
culty in identifying feelings and distinguishing between
feelings and bodily sensations; (ii) difficulty in describing
feelings; (iii) constricted imaginative processes; and (iv) a
stimulus-bound, externally oriented cognitive style [18].
Persons with alexithymia have an impaired ability to
build mental representations of their emotions, and
therefore they misinterpret physical symptoms related to
emotional arousal (i.e., tachycardia or tremors, dyspnea)
as symptoms of somatic diseases. These subjects may in-
crease susceptibility to disease development, therefore
alexithymia is considered as a risk factor for a variety of
medical conditions.
Patients with alexithymia tended to perceive and to
live their disease as a cyclical disorder, not a chronic
condition, and they feel high levels of distress. Further-
more, in alexithymic patients, asthma is less controlled,
independent of the GINA classification of severity [6],
and the lack of control leads to a reduced Health Related
Quality of Life (HRQoL). Alexithymia altered the recog-
nition of sensations and symptoms, judgments, thoughts,
and emotions related to respiratory allergy. Summariz-
ing, in asthmatic patients, the presence of alexithymia
leads to report more serious negative consequences and
emotions, affecting physical, psychological, and social as-
pects of life [19–22]. Literature concerning the links be-
tween alexithymia and asthma helps to identify some of
the reasons for non-optimal disease management.
Studies focused on patients with extremely severe or
nearly fatal attacks, suggest that this personality trait is
associated with disease exacerbations. It has been shown
that a significantly higher prevalence of alexithymia oc-
curs among patients who have experienced a nearly fatal
asthma attack (36 %), compared with patients with
matched asthma severity who have not experienced a
nearly fatal attack (13 %) [20] or with the general popu-
lation (5–13 %). A study evaluating 270 asthmatic sub-
jects during a severe attack showed that alexithymic
patients reported significantly lower scores for nine
symptom and sign categories on the Asthma Symptom
Checklist scale [20]. These results show that alexithymic
patients tend to underestimate both physical and emo-
tional components of asthma exacerbations, irrespective
of of the severity of the disease. A greater frequency of
recurrent hospitalizations due to asthma was found in
alexithymic patients (37.4 versus 28.4 % over 6 months):
the difficulty in recognizing and expressing symptoms
intensity and frequency could lead patients underesti-
mate the risk of asthma exacerbation [22]. In addition,
higher alexithymia scores have been found to be associ-
ated with increased report of asthma symptoms and with
decreased pulmonary function, as indicated by %FEV1/
FVC [23].
A recent observational study shows pulmonary func-
tion and disease control were associates to but not to
anxiety and depression [24]; furthermore the level of
alexithymia correlated positively with mood and anxiety.
Moreover, the presence of alexithymia has been associ-
ated with poor treatment adherence and worse HRQoL.
More in detail, it was found a correlation between alex-
ithymia and intentional non-adherence, that is the result
of an active choice [25].
The prevalence of alexithymia resulted higher than in
general population, indicating that it is a common fea-
ture that characterizes almost 1 patient out of 5 [26].
Despite no differences between alexithymic and non
alexithymic patients were observed for what concerns
GINA severity level, the level of alexithymia was associ-
ated to different disease experiences and outcomes. In
alexithymic patients, asthma is less controlled, independ-
ently of GINA classification, and the lack of control
leads to a poorer HRQoL.
Moreover, in asthmatic patients who develop post trau-
matic stress disorder (PTSD) symptoms after an asthma
attack, alexithymia represents a factor that mediate the
relationship between asthma severity and psychiatric co-
morbidity [27].
Coping strategies
The study of coping describe how people deal with stress-
ful events and ongoing situations [28]. Suffering from a
chronic disease such as asthma predisposes individuals to a
degree of stress that requires continuous cognitive, emo-
tional, behavioral, and social adaptation. Coping efforts
may help to modify the situation, change the meaning of
the experience, or mitigate the stress related to asthma
management (e.g. improve asthma control, accept the dis-
ease, be optimistic about the sickness course). Active cop-
ing strategies addressed directly to the problem are
considered to be adaptive, whereas passive, emotion-
focused coping is related to poor adjustment to illness [28].
Studies of chronic disorders have underlined signifi-
cant associations between coping styles and clinical out-
comes like physical functioning, levels of disease control,
morbidity, mortality and HRQoL [29]. Research suggests
avoidant coping (for example, ignoring, denying, or avoid-
ing a problem) is associated with poor HRQoL among
adult asthma patients [30, 31], whereas active coping
(taking an active approach to the problem, whether cogni-
tive or behavioral) is associated with better HRQoL scores
[30, 31]. Asthmatic patients with effective coping skills
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(characterized by maintaining a positive vision of the dis-
ease without minimizing its potential danger and by using
active, cognitive strategies and flexible and diversified be-
haviors) will experience less psychological morbidity, a
feeling of greater personal control over asthma, and better
long-term management of the disease [32]. In contrast,
the use of avoidance strategies is associated with a lower
level of asthma control, with a worsening of clinical out-
comes, and with a greater number of hospitalizations, un-
scheduled health care visits, and episodes of nearly fatal
asthma [33, 34]. Patients with ineffective coping strategies
tend to have difficult-to-treat asthma: interviews regarding
behaviours to adopt during an hypothetical asthma attacks,
showed that patients suffering from brittle asthma tend
delayed up to 7 days before seeking medical attention [35].
Asthmatic subjects with avoidant strategy preferences
are less adherent to medical therapy and prone to re-
liever drug abuse and to inadequate controller drug use
[32]. Coping skills training and educational interventions
aimed at improving coping strategies can increase a sub-
jective sense of competence and self-efficacy in dealing
with a wide range of daily demands and health issues,
with benefits not only to asthma symptoms but also to
psychological functioning, sense of well-being, and
anxiety [36].
A large, cross-sectional survey, involving 6,474 pa-
tients and 3,089 general practitioners [29], explored cop-
ing in asthma management. Active coping strategies
were described by approximately one-half of the pa-
tients, whereas the physicians reported a significantly
lower frequency of effective coping strategies in their pa-
tients. A similar percentage of patients and a greater
percentage of physicians reported the use of negative
strategies, with “rely on fate or faith” chosen more fre-
quently by patients than physicians. The degree of con-
cordance between the choices of patients and general
practitioners was only fair, indicating inadequate pa-
tient–physician communication.
Depression and anxiety
Asthma has long been associated with symptoms of
mood and anxiety disorders [37, 38].
Available studies show that the prevalence of anxiety
and depressive disorders is more elevated among
asthma patients than in general population. However,
the association of mental health problems with asthma
severity is controversial. Some studies have shown sig-
nificantly higher level of anxiety and depression in pa-
tients with severe asthma as compared to those with
milder disease, while other studies did not detect such
differences [39, 40].
Clinical data has shown that the presence of psychiatric
and psychological symptoms is associated with increased
severity of asthma symptomatology, health service use
and costs, functional impairment and poorer asthma con-
trol [41–44].
Depression would be significantly worse among se-
vere asthmatics as compared to those with less severe
asthma, and lower levels of asthma control would ex-
plain the greater degree of depressive symptoms in se-
vere asthma. Individuals with severe asthma endorsed
more symptoms of depression than those with milder
asthma, with the severe asthmatics who endorsed poor
asthma control being at particularly heightened risk.
Psychological morbidity seems to be associated with in-
creases in asthma severity, routine screening for de-
pression among patients with severe asthma may result
in the opportunity to tailor patient-centred clinical
asthma management efforts resulting in improved dis-
ease management and control [40].
Children and adolescents with symptomatic asthma
are more likely to suffer from a wide range of mental
health problems, compared to healthy children. The like-
lihood of mental health problems appears closely associ-
ated to asthma severity. Youth with poorly controlled
and/or more severe and persistent asthma may be con-
sidered a group at high vulnerability for mental health
problems. Management for paediatric asthma should in-
clude screening tools and counselling interventions to
detect, prevent and reduce the risk of mental health
problems [40].
A study of 67 adults with severe prednisone-dependent
asthma, 47 with severe non prednisone dependent and 73
patients with mild-moderate asthma [45] was aimed to in-
vestigate the prevalence of anxiety and depression symp-
toms. That research suggests that there are significantly
more anxiety and depression symptoms in patients with
severe prednisone dependent asthma compared to pa-
tients with non-steroid dependent severe asthma or
mild-moderate asthma: patients with prednisone-
dependent asthma were 3.5 times more likely to have
clinically significant depression symptoms, and about
2.5 times more likely to have significant anxiety symp-
toms as compared to patients with severe or mild-
moderate disease. However, the available data about the
effect of steroids on mood are poor and few controlled
studies have been performed to assess treatment for
steroids induced psychiatric, cognitive and behavioural
problems [46].
A cross-sectional study conducted at the Asthma
Outpatient Clinic of the Federal University of São Paulo
Hospital São Paulo [47] show how the prevalence of
anxiety is higher in the patients with uncontrolled
asthma than in those with controlled asthma.
In stable primary care patients, both physician and
patient-reported depressive symptoms were associated
to asthma severity. On the contrary, an association be-
tween depression and level of asthma control has been
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detected according patients’ reports, but not in those of
physicians [48].
The available evidence suggests that asthma may pre-
cede and predispose to the development of anxiety and
mood disorders, but also that the presence of psycho-
logical and behavioural problems may precede and pre-
dispose to asthma [49].
From a neurobiological perspective, several interesting
hypotheses have been suggested with the aim to explain
the association between asthma ad mood disorders:
systemic inflammation seems to be a key link between
these conditions and studies conducted so far suggesting
a possible role of cytokines in the neurotransmission in
the central nervous system (CNS) [50].
Conclusion
The psychological characteristics of asthmatic patients
and the presence of mental problems, have been shown
to be linked to both asthma severity and level of disease
control. Difficulties in achieving the objectives of asthma
therapy suggested by current guidelines may depend also
on psychological factors such as symptoms’ perception,
alexithymia, coping strategies, mood disorders.
Despite numerous data support this association, a
causal relationship between asthma and mental health is
not clear. The hypothesis of a bidirectional influence
seems to be more acceptable.
Independently of the nature of this association, when a
psychological problem or difficulty is present, it inter-
feres with an optimal disease management, especially in
patients with severe asthma and poor control. At the
same time, the psychological characteristics of asthmatic
patients have an influence on symptoms’ recognitions,
daily management and disease outcomes.
A screening of mental symptoms and psychological as-
pects that are known as associated to asthma, could lead
to plan appropriate intervention to better control asthma
and to improve the patient’s well-being.
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